title: Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.
authors.affiliation: a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.
authors.forename: Tarec C
authors.initials: TC
authors.lastname: El-Galaly
authors.affiliation: a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.
authors.forename: Anders E
authors.initials: AE
authors.lastname: Bilgrau
authors.affiliation: b Department of Hematology , Herlev University Hospital , Herlev , Denmark.
authors.forename: Eva
authors.initials: E
authors.lastname: Gaarsdal
authors.affiliation: b Department of Hematology , Herlev University Hospital , Herlev , Denmark.
authors.forename: Tobias W
authors.initials: TW
authors.lastname: Klausen
authors.affiliation: b Department of Hematology , Herlev University Hospital , Herlev , Denmark.|c Department of Hematology , Roskilde University Hospital , Roskilde , Denmark.
authors.forename: Lars M
authors.initials: LM
authors.lastname: Pedersen
authors.affiliation: d Department of Clinical Immunology , Aalborg University Hospital , Aalborg , Denmark.
authors.forename: Kaspar R
authors.initials: KR
authors.lastname: Nielsen
authors.affiliation: d Department of Clinical Immunology , Aalborg University Hospital , Aalborg , Denmark.
authors.forename: John
authors.initials: J
authors.lastname: Bæch
authors.affiliation: a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.|e Clinical Cancer Research Center, Aalborg University Hospital , Aalborg , Denmark.|f Department of Clinical Medicine , Aalborg University , Aalborg , Denmark.
authors.forename: Martin
authors.initials: M
authors.lastname: Bøgsted
authors.affiliation: a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.|e Clinical Cancer Research Center, Aalborg University Hospital , Aalborg , Denmark.|f Department of Clinical Medicine , Aalborg University , Aalborg , Denmark.
authors.forename: Karen
authors.initials: K
authors.lastname: Dybkær
authors.affiliation: g Department of Medicine and Oncology , Herlev University Hospital , Herlev , Denmark.
authors.forename: Julia S
authors.initials: JS
authors.lastname: Johansen
authors.affiliation: a Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.|b Department of Hematology , Herlev University Hospital , Herlev , Denmark.|e Clinical Cancer Research Center, Aalborg University Hospital , Aalborg , Denmark.|f Department of Clinical Medicine , Aalborg University , Aalborg , Denmark.
authors.forename: Hans E
authors.initials: HE
authors.lastname: Johnsen
mesh_terms: D054392:Adipokines / Q000097:blood*; D015415:Biomarkers; D000071451:Chitinase-3-Like Protein 1; D006801:Humans; D037102:Lectins / Q000097:blood*; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D016879:Salvage Therapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*
chemical_list: D054392:Adipokines; D015415:Biomarkers; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D037102:Lectins; D014409:Tumor Necrosis Factor-alpha